MPS Limited (IN:MPSLTD)
:MPSLTD
Top Page
MPS Limited
(MPSLTD)
Select Model
Select Model
Rating:73Outperform
Price Target:
₹1,905.00
▼(-2.34% Downside)
Action:ReiteratedDate:02/14/26
The score is driven primarily by strong financial performance and healthy cash generation, with valuation support from a moderate P/E and strong dividend yield. These positives are partially offset by very weak technical momentum, with the stock trading well below key moving averages and bearish MACD signals.
Positive Factors
Strong cash generation
Operating cash flow consistently exceeding net income and positive free cash flow growth indicate high-quality earnings and internal funding capacity. This durable cash generation supports dividends, reinvestment in technology/platform offerings, and lowers reliance on external financing for growth or working capital needs.
Negative Factors
Contract concentration risk
Revenue dependence on large, multi-year client contracts creates concentration and renewal risk: non-renewal or downsizing by a key publisher can materially impact revenue. While multi-year deals add stability, they also concentrate negotiating leverage with major customers and raise exposure to a few counterparties.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Operating cash flow consistently exceeding net income and positive free cash flow growth indicate high-quality earnings and internal funding capacity. This durable cash generation supports dividends, reinvestment in technology/platform offerings, and lowers reliance on external financing for growth or working capital needs.
Read all positive factors
MPS Limited (MPSLTD) vs. iShares MSCI India ETF (INDA)
Market Cap
₹25.79B
Dividend Yield4.14%
Average Volume (3M)942.00
Price to Earnings (P/E)24.3
Beta (1Y)1.16
Revenue Growth16.76%
EPS Growth50.15%
CountryIN
Employees2,406
SectorServices
Sector StrengthN/A
IndustryPublishing
Share Statistics
EPS (TTM)20.90
Shares Outstanding17,105,816
10 Day Avg. Volume826
30 Day Avg. Volume942
Financial Highlights & Ratios
PEG Ratio1.30
Price to Book (P/B)10.27
Price to Sales (P/S)6.76
P/FCF Ratio51.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,801.00Price Target Upside43.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)97.45
Revenue Forecast (FY)₹7.96B
MPS Limited Business Overview & Revenue Model
Company Description
MPS Limited provides platforms and services for content creation, full-service production, and distribution to the publishers, learning companies, corporate institutions, libraries, and content aggregators in India, Europe, the United States, and ...
How the Company Makes Money
MPS Limited generates revenue through multiple key streams, including content creation services, digital publishing solutions, and editorial services tailored to clients in the publishing and education sectors. The company's revenue model is large...
MPS Limited Financial Statement Overview
Summary
Income Statement
90
Very Positive
Balance Sheet
85
Very Positive
Cash Flow
88
Very Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.49B | 7.27B | 5.45B | 5.01B | 4.46B | 4.23B |
| Gross Profit | 4.73B | 2.57B | 5.45B | 5.01B | 4.46B | 4.22B |
| EBITDA | 2.47B | 2.23B | 1.82B | 1.67B | 1.40B | 1.16B |
| Net Income | 1.78B | 1.49B | 1.19B | 1.09B | 871.21M | 585.60M |
Balance Sheet | ||||||
| Total Assets | 7.04B | 6.95B | 7.37B | 5.52B | 4.97B | 5.07B |
| Cash, Cash Equivalents and Short-Term Investments | 1.21B | 1.06B | 1.45B | 1.85B | 1.38B | 1.11B |
| Total Debt | 101.00M | 36.90M | 45.41M | 75.80M | 119.85M | 183.50M |
| Total Liabilities | 2.14B | 2.17B | 2.77B | 1.33B | 1.30B | 1.26B |
| Stockholders Equity | 4.90B | 4.78B | 4.60B | 4.24B | 3.67B | 3.81B |
Cash Flow | ||||||
| Free Cash Flow | 1.01B | 946.70M | 1.14B | 1.08B | 1.10B | 926.28M |
| Operating Cash Flow | 1.05B | 1.01B | 1.18B | 1.13B | 1.14B | 993.72M |
| Investing Cash Flow | -160.10M | -57.70M | 251.37M | -647.40M | 153.59M | -592.89M |
| Financing Cash Flow | -880.70M | -1.40B | -933.65M | -701.00M | -1.16B | -529.34M |
MPS Limited Technical Analysis
Neutral
1950.70
Price Trends
1636.64
Negative
1866.59
Negative
2115.00
Negative
Market Momentum
-38.31
Negative
47.41
Neutral
44.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MPSLTD, the sentiment is Neutral. The current price of 1950.7 is above the 20-day moving average (MA) of 1473.42, above the 50-day MA of 1636.64, and below the 200-day MA of 2115.00, indicating a neutral trend. The MACD of -38.31 indicates Negative momentum. The RSI at 47.41 is Neutral, neither overbought nor oversold. The STOCH value of 44.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:MPSLTD.
MPS Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹25.79B | 24.27 | ― | 4.14% | 16.76% | 50.15% | |
73 Outperform | ₹48.04B | 10.48 | ― | 7.35% | -3.25% | 60.80% | |
68 Neutral | ₹53.03B | 30.24 | ― | 0.25% | 13.96% | 31.69% | |
63 Neutral | ₹18.02B | 25.07 | ― | 1.37% | -2.79% | -26.28% | |
60 Neutral | ₹17.28B | 25.35 | ― | ― | 3.88% | -3.40% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% |
* Services Sector Average
IN:MPSLTD
MPS Limited
1,507.70
-1,213.08
-44.59%
IN:HATHWAY
Hathway Cable & Datacom Ltd.
9.76
-3.25
-24.98%
IN:PTC
PTC India Limited
162.30
15.57
10.61%
IN:SJS
S.J.S. Enterprises Limited
1,658.40
781.14
89.04%
IN:TCIEXP
TCI Express Ltd.
469.10
-170.54
-26.66%
MPS Limited Corporate Events
MPS Limited Completes USD 16.5 Million Acquisition of Unbound Medicine in the U.S.
Feb 9, 2026
MPS Limited has completed the acquisition of Unbound Medicine, Inc. in the U.S. through its wholly owned subsidiary, MPS North America LLC, following the execution of a stock purchase agreement signed on January 30, 2026. The deal, valued at USD 1...
MPS Limited to Host Investor Call on Unbound Medicine Acquisition
Feb 9, 2026
MPS Limited has scheduled a conference call on 18 February 2026 to discuss its acquisition of U.S.-based Unbound Medicine Inc. The call will be led by Chairman and CEO Rahul Arora, alongside the senior management team, and will be accessible to in...
MPS Limited Details Funding Plan for Unbound Medicine Acquisition via Subsidiary
Feb 4, 2026
MPS Limited has detailed the funding structure for its wholly owned subsidiary MPS North America LLC’s proposed USD 16.5 million acquisition of US-based Unbound Medicine, Inc. The deal will be financed through a mix of internal accruals, int...
MPS Limited Enters Healthcare Tech With $16.5 Million Unbound Medicine Acquisition
Jan 30, 2026
MPS North America LLC, a wholly owned subsidiary of MPS Limited, has signed a stock purchase agreement to acquire 100% of Unbound Medicine, Inc., a U.S.-based healthcare learning technology company, for USD 16.5 million, subject to customary adjus...
MPS North America to Acquire Unbound Medicine in Strategic Healthcare Tech Push
Jan 30, 2026
MPS North America LLC, the wholly owned U.S. subsidiary of MPS Limited, has agreed to acquire a 100% stake in Unbound Medicine, Inc., a U.S.-based provider of digital medical reference, clinical decision-support, and healthcare learning solutions ...
MPS Limited Says Surge in Share Volume Is Market-Driven, No Undisclosed News
Jan 9, 2026
MPS Limited has responded to a query from the National Stock Exchange of India regarding a recent sharp increase in trading volume in its shares, stating that it is not aware of any undisclosed information or impending announcements that could exp...
MPS Limited Reports Q2 and H1 2025 Financial Results
Nov 19, 2025
MPS Limited conducted an earnings conference call to discuss its unaudited financial results for the second quarter and half-year ending September 30, 2025. The call, led by key management figures, highlighted the company’s financial perform...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.